Articles by Laurence G. Poli - Pharmaceutical Executive

ADVERTISEMENT

Articles by Laurence G. Poli

Forecast 2007: Connecting the Dots

How do execs rank the issues facing the industry? And what are the links they see between them? A new study, conducted for Pharm Exec by researchers at the University of the Sciences in Philadelphia, reveals the industry's mental map of today's challenges.
Jan 1, 2007

Pharma faces a wide array of pressing issues—almost too many to think about comfortably—from drug safety and the industry's image to intellectual property in emerging markets and the overall usefulness of marketing. To remain effectively focused on strategy, industry executives must find relations between all the individual issues and group them into larger themes. Pragmatically, we all know this is essential.

Back Page: Pharma's Mega-Brands

The industry's biggest blockbusters bring in more revenue than many Fortune 500 companies. So why not manage them that way?
Oct 1, 2006

Almost $60 billion of the drug industry's global sales comes from just 10 drugs. In fact, these so-called "mega-brands" have sales so high that they are bigger than many Fortune 500 companies. So why aren't they being managed that way?

ADVERTISEMENT

Click here